| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Additional value and potential use of the 70-gene prognosis signature in node-negative breast cancer in daily clinical practice
|
Bueno-de-Mesquita, J.M.
|
|
|
22 |
9 |
p. 2021-2030
|
article
|
| 2 |
Alcohol drinking and colorectal cancer risk: an overall and dose–response meta-analysis of published studies
|
Fedirko, V.
|
|
|
22 |
9 |
p. 1958-1972
|
article
|
| 3 |
A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection
|
Wong, R.
|
|
|
22 |
9 |
p. 2042-2048
|
article
|
| 4 |
A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer
|
Blumenschein Jr, G.R.
|
|
|
22 |
9 |
p. 2057-2067
|
article
|
| 5 |
A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors
|
Mahadevan, D.
|
|
|
22 |
9 |
p. 2137-2143
|
article
|
| 6 |
Circulating cancer cells in division in an early breast cancer patient
|
Serrano, M.J.
|
|
|
22 |
9 |
p. 2150-2151
|
article
|
| 7 |
Correction to: EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis in non-small-cell lung cancer
|
|
|
|
22 |
9 |
p. 2155
|
article
|
| 8 |
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial
|
Brisbois, T.D.
|
|
|
22 |
9 |
p. 2086-2093
|
article
|
| 9 |
Dietary and supplemental intake of one-carbon nutrients and the risk of type I and type II endometrial cancer: a prospective cohort study
|
Uccella, S.
|
|
|
22 |
9 |
p. 2129-2136
|
article
|
| 10 |
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX
|
Aebi, S.
|
|
|
22 |
9 |
p. 1981-1987
|
article
|
| 11 |
Does the addition of chemotherapy to adjuvant endocrine treatment add any benefit in ER-positive early breast cancer: can we rely on large randomized control trials in the era of personalized medicine?
|
Glück, S.
|
|
|
22 |
9 |
p. 1937-1938
|
article
|
| 12 |
Editorial Board
|
|
|
|
22 |
9 |
p. ii-iii
|
article
|
| 13 |
Identification of a subpopulation of metastatic breast cancer patients with very high HER2 expression levels and possible resistance to trastuzumab
|
Bates, M.
|
|
|
22 |
9 |
p. 2014-2020
|
article
|
| 14 |
Imatinib treatment duration is related to decreased estimated glomerular filtration rate in chronic myeloid leukemia patients
|
Marcolino, M.S.
|
|
|
22 |
9 |
p. 2073-2079
|
article
|
| 15 |
Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly
|
Fritsch, K.
|
|
|
22 |
9 |
p. 2080-2085
|
article
|
| 16 |
Impact of neutropenia on the outcomes of critically ill patients with cancer: a matched case–control study
|
Souza-Dantas, V.C.
|
|
|
22 |
9 |
p. 2094-2100
|
article
|
| 17 |
Impact of sunitinib pharmacokinetic monitoring in a patient with metastatic renal cell carcinoma undergoing hemodialysis
|
Thiery-Vuillemin, A.
|
|
|
22 |
9 |
p. 2152-2154
|
article
|
| 18 |
Incidental versus symptomatic venous thrombosis in cancer: a prospective observational study of 340 consecutive patients
|
Font, C.
|
|
|
22 |
9 |
p. 2101-2106
|
article
|
| 19 |
Late referrals to home palliative care service affecting death at home in advanced cancer patients in Japan: a nationwide survey
|
Fukui, S.
|
|
|
22 |
9 |
p. 2113-2120
|
article
|
| 20 |
Long-term toxic effects of adjuvant chemotherapy in breast cancer
|
Azim Jr, H.A.
|
|
|
22 |
9 |
p. 1939-1947
|
article
|
| 21 |
Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients
|
Maringwa, J.
|
|
|
22 |
9 |
p. 2107-2112
|
article
|
| 22 |
Novel approaches and future directions in castration-resistant prostate cancer
|
Nabhan, C.
|
|
|
22 |
9 |
p. 1948-1957
|
article
|
| 23 |
Oligohydramnios associated with administration of weekly paclitaxel for triple-negative breast cancer during pregnancy
|
Shieh, M.P.
|
|
|
22 |
9 |
p. 2151-2152
|
article
|
| 24 |
Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer
|
Zweifel, M.
|
|
|
22 |
9 |
p. 2036-2041
|
article
|
| 25 |
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel±darbepoetin alfa in primary breast cancer—results at the time of surgery
|
Untch, M.
|
|
|
22 |
9 |
p. 1988-1998
|
article
|
| 26 |
PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin–cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer—outcome on prognosis
|
Untch, M.
|
|
|
22 |
9 |
p. 1999-2006
|
article
|
| 27 |
Response to influenza virus vaccination during chemotherapy in patients with breast cancer
|
Meerveld-Eggink, A.
|
|
|
22 |
9 |
p. 2031-2035
|
article
|
| 28 |
Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group
|
Stupp, R.
|
|
|
22 |
9 |
p. 2144-2149
|
article
|
| 29 |
Significance of smoking history and FDG uptake for pathological N2 staging in clinical N2-negative non-small-cell lung cancer
|
Na, I.I.
|
|
|
22 |
9 |
p. 2068-2072
|
article
|
| 30 |
1st ESMO Consensus Conference in lung cancer; Lugano 2010: Small-cell lung cancer
|
Stahel, R.
|
|
|
22 |
9 |
p. 1973-1980
|
article
|
| 31 |
Table of Contents
|
|
|
|
22 |
9 |
p. iv-vi
|
article
|
| 32 |
Tumor–ratio–metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection—results of a single-institution study of 1343 Chinese patients
|
Wang, W.
|
|
|
22 |
9 |
p. 2049-2056
|
article
|
| 33 |
Usefulness of a bidirectional e-learning material for explaining surgical anesthesia to cancer patients
|
Narimatsu, H.
|
|
|
22 |
9 |
p. 2121-2128
|
article
|
| 34 |
Very high quantitative tumor HER2 content and outcome in early breast cancer
|
Joensuu, H.
|
|
|
22 |
9 |
p. 2007-2013
|
article
|
Journal description